Abstract Submission Deadline: November 11th 2016 (23:59h GMT+1)
Abstract submission will open soon
To facilitate the blinded peer review process and to ensure that abstracts are properly formatted, we suggest the following format, which is similar to the suggested abstract format for the general ISMRM meeting and supplemental to the instructions at the upload web site.
- During submission, a file is uploaded which contains only the body of the abstract (NO TITLE, AUTHORS, AFFILIATIONS, OR SYNOPSIS, all of which are captured in data entry fields at the upload site).
- The uploaded abstract file must be in .doc, or .docx format
- Margins: Please use a top margin of 0.5″ (1.25 cm) and right and left margins of 0.5″ (1.25 cm). The bottom margin must also be set at 0.5” with 2” of clear space left above that (total of 2.5″ of space from the bottom of the page) to allow for insertion of the title/author text at the top of the page. Text will be pushed onto a second page if you set the bottom margin at 2.5” resulting in a document that is too long.
- Fonts: Please use standard fonts such as Arial, Times, or Times New Roman. The font size should be 8pt or larger.
- The text should be formatted in one column across the page
Example abstract → click here to open
SUGGESTED ISMRM Benelux Chapter abstract format:
(Please note this is only a guideline, understanding that some abstracts will not necessarily lend themselves to this format)
- Include within your abstract the following sections. In each section, answer the question listed below. (Do not repeat the actual question in the body of your abstract.)
- TARGET AUDIENCE – “Who will benefit from this information?”
- PURPOSE – “Why was this study/research performed?”
- METHODS – “How has this problem been studied?”
- RESULTS – “Principal data and statistical analysis”
- DISCUSSION – “What is the interpretation of the data?”
- CONCLUSION – “What is the relevance to clinical practice or future research?”
- REFERENCES – References are optional, using the suggested style below.
Citations in the body of the abstract
Cite each source in numerical order using superscript Arabic numerals (1, 2, 3…).
- Example 1: A review of regulations has been complete by the WHO15.
- Example 2: The data were as follows3,4: Example 3: As previously reported,11-14,25
Citations in the reference list
At the end of the document, list references numerically in the order by which they were cited in the text.
- Example 1: 1. Rainier S, Thomas D, Tokarz D, et al. Myofibrillogenesis regulator 1 gene mutations cause paroxysmal dystonic choreoathetosis. Arch Neurol. 2004;61(7):1025‐1029.
- Example 2: 2. World Health Organization. Injury: A Leading Cause of the Global Burden of Disease, 2000. Geneva, Switzerland: World Health Organization; 2002.
- Example 3: 3. Weiss R. The promise of precision prescriptions. Washington Post. June 24, 2000:A1. http://www.washingtonpost.com. Accessed October 10, 2001.
General Content Guidelines
- The content may not promote the proprietary interests of any commercial entity. Evident bias in favor of a particular product or company is grounds for rejection.
- Content must be restricted to pure science, industry issues and operation of devices, Product /company names should be included only to identify the MR hardware/software/ peripherals used, but not to promote proprietary interests (see Point 1)
- All recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients.
- All scientific research referred to, reported or used in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection and analysis.
- The Proceedings will be published electronically on this website. The full text of all accepted abstracts will be available online two weeks before the meeting to pre-registered attendees only. If you wish to have access to the Proceedings before the meeting, you must pre-register.
- All submitted abstracts are treated as confidential from the time of submission to the publication date, 16 January 2015.
- All copyrights to accepted abstracts become the property of ISMRM Benelux Chapter. No proprietary information may be withheld by authors.
- Innovation/novelty, advancement of knowledge, and/or improvement of clinical capabilities.
- Data: The data should be substantive and not just implied.
- Organization of presentation (hypothesis or objectives, methods, results, discussion/conclusions.)
- Abstracts should have relevance for current or future application.
- Quality of presentation (spelling, format, grammar).
- Bias: Evident bias in favor of a particular product or company is grounds for rejection. (Use of a particular company’s products or equipment in itself does not represent bias. Non-data-driven statements of superiority, however, would be considered biased.)
- Evidence that is accepted within the profession. All recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients.
- Conformance to generally accepted standards of experimental design. All scientific research referred to, reported or used in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection and analysis.
- Repetition of Content. Multiple submissions of the same or nearly the same abstract is grounds for rejection.
Additional Important Points
– Number of Abstracts per Author
Each first author is allowed to send in only one abstract! Additional abstracts of the same first author will NOT be reviewed, so make sure to send in your finest work ONLY!
A 100-word synopsis of each abstract must be submitted. It should include a brief summary of the problem, methods, results, and conclusions. The synopsis must include text only, without equations or images and be without references or citations to items described in the full abstract. To conserve space and provide authors greater opportunity to clarify their projects, the synopsis should NOT appear in the actual abstract.
– Review Category
By choosing a review category, you enable us to assign your abstract to the most appropriate reviewers, and to construct unified and logical scientific sessions at the meeting. However, not every abstract fits neatly into a single category, and sometimes identification of a secondary category might be helpful during the review and program construction process and ensures that your abstract is sent to the optimal combination of reviewers, with the most relevant expertise to the content of your abstract. If you feel that your abstract belongs in more than one category, you can indicate a second area of review or emphasis.
– Failure to Present
Submission of an abstract is considered a commitment to present the abstract if it is accepted. Failure to present an abstract may jeopardize future submissions by the same author or institution.
– The Proceedings will be published electronically only. The full text of all accepted abstracts will be available online two weeks before the meeting to pre-registered attendees only (20 January 2016). If you wish to have access to the Proceedings before the meeting, you must pre-register.
– All submitted abstracts are treated as confidential from the time of submission to the publication date, 20 January 2017.
– All copyrights to accepted abstracts become the property of ISMRM. No proprietary information may be withheld by authors.* Power Posters: During the first part of the session, authors of selected abstracts (best ranked abstracts) will be asked to make a five-minute oral ‘poster pitch’ with slides. During lunch, authors will have the chance to present the work as a poster during a 45-minute period to engage in more detailed discussions.